title: Session 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.
authors: Purification Process Development, BioProcess R&D, Pfizer Inc., One Burtt Road, Andover, MA 01810; (978) 247-3716; Chris.Gallo@pfizer.com Chris.Gallo@pfizer.com.
authors: Christopher
authors: C
authors: Gallo
mesh_terms: D000818:Animals; D001709:Biotechnology; D002845:Chromatography; D003412:Cricetulus; D004340:Drug Contamination; D007700:Kinetics; D014780:Viruses